|
US4017500A
(en)
|
1973-07-16 |
1977-04-12 |
Schering Corporation |
Certain 8-amino-1,7-naphthyridines
|
|
DE2908324A1
(de)
|
1979-03-03 |
1980-09-18 |
Hoechst Ag |
Triazolsubstituierte hydratopasaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschutzmittel
|
|
US4792562A
(en)
|
1985-12-04 |
1988-12-20 |
Hoechst-Roussel Pharmaceuticals, Inc. |
N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
|
|
JPH0532662A
(ja)
|
1990-11-09 |
1993-02-09 |
Nissan Chem Ind Ltd |
置換ピラゾール誘導体および農園芸用殺菌剤
|
|
US5214038A
(en)
|
1991-04-15 |
1993-05-25 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
|
|
DE4120107A1
(de)
|
1991-06-14 |
1992-12-17 |
Schering Ag |
Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
|
|
TW343965B
(en)
|
1994-03-30 |
1998-11-01 |
Hoffmann La Roche |
Novel mono- and bicyclic DNA gyrase inhibitors
|
|
AU2381397A
(en)
|
1996-04-19 |
1997-11-12 |
Novo Nordisk A/S |
Modulators of molecules with phosphotyrosine recognition units
|
|
EP0887348A1
(en)
|
1997-06-25 |
1998-12-30 |
Boehringer Mannheim Italia S.p.A. |
Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
|
|
JP3712529B2
(ja)
|
1998-04-24 |
2005-11-02 |
大鵬薬品工業株式会社 |
３，３−ジピリジルアクリル酸アミド誘導体又はその薬学的に許容される塩
|
|
EP1793262B1
(en)
|
1999-02-12 |
2014-10-29 |
Hoya Corporation |
Spectacle lens and manufacturing method therefor
|
|
AU4692400A
(en)
*
|
1999-05-03 |
2000-11-17 |
Smithkline Beecham Corporation |
Cxcr-4 receptor antagonists - thrombopoietin mimetics
|
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
|
GB9929988D0
(en)
|
1999-12-17 |
2000-02-09 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6608053B2
(en)
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
WO2001083456A1
(en)
|
2000-04-27 |
2001-11-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Condensed heteroaryl derivatives
|
|
WO2002002551A1
(en)
|
2000-06-30 |
2002-01-10 |
Sugen, Inc. |
4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
|
|
JP2004512336A
(ja)
*
|
2000-09-15 |
2004-04-22 |
アノーメッド インコーポレイティド |
ケモカインレセプター結合複素環式化合物
|
|
JP2002255964A
(ja)
|
2000-10-24 |
2002-09-11 |
Sankyo Co Ltd |
イミダゾピリジン誘導体
|
|
WO2002034748A1
(fr)
|
2000-10-24 |
2002-05-02 |
Sankyo Company, Limited |
Derives d'imidazopyridine
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
|
WO2003076400A1
(en)
*
|
2002-03-13 |
2003-09-18 |
Janssen Pharmaceutica N.V. |
New inhibitors of histone deacetylase
|
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
JP4235726B2
(ja)
|
2002-11-19 |
2009-03-11 |
国立大学法人 奈良先端科学技術大学院大学 |
大きな二光子吸収特性を示すアセチレン結合により連結されたビス（イミダゾリルポルフィリン金属錯体）を構成単位とするポルフィリン連鎖体及びその製造方法
|
|
AU2003900608A0
(en)
|
2003-02-11 |
2003-02-27 |
Fujisawa Pharmaceutical Co., Ltd. |
Hdac inhibitor
|
|
CN1922171B
(zh)
|
2004-02-26 |
2012-10-17 |
Aska制药株式会社 |
嘧啶衍生物
|
|
AU2005250116B2
(en)
|
2004-06-01 |
2011-01-20 |
F. Hoffmann-La Roche Ag |
3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
|
|
CN101076372A
(zh)
|
2004-10-06 |
2007-11-21 |
里斯普蒂康公司 |
化合物用于预防药物诱导的细胞毒性的用途
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
JP2008530136A
(ja)
*
|
2005-02-14 |
2008-08-07 |
ミイカナ セラピューティクス インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物
|
|
SG171690A1
(en)
|
2005-03-22 |
2011-06-29 |
Harvard College |
Treatment of protein degradation disorders
|
|
ES2380795T3
(es)
|
2005-05-20 |
2012-05-18 |
Vertex Pharmaceuticals, Inc. |
Pirrolopiridinas útiles como inhibidores de proteínas quinasas
|
|
TW200716545A
(en)
|
2005-06-10 |
2007-05-01 |
Sigma Tau Ind Farmaceuti |
Indole derivatives having anti-tumor activity
|
|
JP5140597B2
(ja)
|
2005-10-21 |
2013-02-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
カリウムチャネル阻害剤
|
|
EP1979353A2
(en)
|
2006-01-19 |
2008-10-15 |
OSI Pharmaceuticals, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
|
TW200801012A
(en)
|
2006-04-26 |
2008-01-01 |
Piramed Ltd |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
CA2650196A1
(en)
|
2006-04-26 |
2007-11-01 |
Stewart James Baker |
Pyrimidine derivatives as pi3k inhibitors
|
|
JPWO2008007780A1
(ja)
|
2006-07-13 |
2009-12-10 |
協和発酵キリン株式会社 |
ペンタジエナミド誘導体
|
|
KR101433629B1
(ko)
|
2006-09-11 |
2014-08-27 |
쿠리스 인코퍼레이션 |
아연 결합 부분을 함유한 티로신 키나아제 억제제
|
|
RU2459811C2
(ru)
*
|
2006-10-28 |
2012-08-27 |
Метилджен Инк. |
Ингибиторы гистоновой деацетилазы
|
|
JP5178731B2
(ja)
|
2006-11-22 |
2013-04-10 |
カルス セラピューティクス リミテッド |
デプシペプチドおよびその治療的使用
|
|
CA2677096A1
(en)
|
2007-01-31 |
2008-08-07 |
Vertex Pharmaceuticals Incorporated |
Kinase inhibitors
|
|
CN101663276A
(zh)
|
2007-01-31 |
2010-03-03 |
沃泰克斯药物股份有限公司 |
用作激酶抑制剂的2-氨基吡啶衍生物
|
|
CN101679220A
(zh)
|
2007-04-09 |
2010-03-24 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
|
US8318781B2
(en)
|
2007-04-26 |
2012-11-27 |
Japan Science And Technology Agency |
G-protein-conjugated receptor agonist
|
|
WO2008137270A1
(en)
|
2007-05-04 |
2008-11-13 |
H. Lundbeck A/S |
Methods of diagnosing and monitoring of npy y5 based disorders
|
|
JP2010529031A
(ja)
|
2007-05-29 |
2010-08-26 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
Ｐｉ３キナーゼ阻害剤としてのナフチリジン誘導体
|
|
GB0710528D0
(en)
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009063240A1
(en)
|
2007-11-16 |
2009-05-22 |
Arrow Therapeutics Limited |
2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase
|
|
WO2009137462A2
(en)
*
|
2008-05-05 |
2009-11-12 |
Envivo Pharmaceuticals, Inc. |
Methods for treating cognitive disorders using inhibitors of histone deacetylase
|
|
WO2010015520A1
(de)
|
2008-08-05 |
2010-02-11 |
Boehringer Ingelheim International Gmbh |
Substituierte naphthyridine und ihre verwendung als arzneimittel
|
|
WO2010037765A2
(en)
|
2008-10-03 |
2010-04-08 |
Merck Serono S.A. |
4-morpholino-pyrido[3,2-d]pyrimidines
|
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
US8748458B2
(en)
|
2009-01-28 |
2014-06-10 |
Karus Therapeutics Limited |
Scriptaid isosteres and their use in therapy
|
|
CA2768466C
(en)
|
2009-07-22 |
2018-08-14 |
The Board Of Trustees Of The University Of Illinois |
Hdac inhibitors and therapeutic methods using the same
|
|
NZ597983A
(en)
|
2009-08-20 |
2014-05-30 |
Karus Therapeutics Ltd |
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
|
|
GB201007347D0
(en)
|
2010-04-30 |
2010-06-16 |
Karus Therapeutics Ltd |
Compounds
|
|
DK2624832T3
(en)
|
2010-10-08 |
2018-01-08 |
Vib Vzw |
HDAC INHIBITORS FOR TREATMENT OF CHARCOT-MARIE-TOOTHS DISEASE
|
|
BR112013014914B8
(pt)
|
2010-12-16 |
2020-08-04 |
Hoffmann La Roche |
composto, composição farmacêutica e uso de um composto
|
|
WO2012106343A2
(en)
|
2011-02-01 |
2012-08-09 |
The Board Of Trustees Of The University Of Illinois |
Hdac inhibitors and therapeutic methods using the same
|
|
EP2508510A1
(en)
|
2011-04-06 |
2012-10-10 |
Ikerchem, S.L. |
Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
|
|
US9512083B2
(en)
|
2011-07-20 |
2016-12-06 |
The General Hospital Corporation |
Histone deacetylase 6 selective inhibitors for the treatment of bone disease
|
|
AU2012319188B2
(en)
|
2011-10-03 |
2016-11-24 |
Sloan-Kettering Institute For Cancer Research |
Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
|
|
CN103957908A
(zh)
|
2011-10-04 |
2014-07-30 |
肝炎和病毒研究所 |
作为包括肝细胞癌在内的癌症的抑制剂和作为肝炎病毒复制抑制剂的取代的氨基噻唑
|
|
CA2846066A1
(en)
*
|
2011-10-28 |
2013-05-02 |
Chong Kun Dang Pharmaceutical Corp. |
Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
|
|
PL2790705T3
(pl)
|
2011-12-15 |
2018-06-29 |
Novartis Ag |
Zastosowanie inhibitorów czynności lub funkcji PI3K
|
|
KR101415742B1
(ko)
|
2011-12-21 |
2014-07-04 |
영남대학교 산학협력단 |
6―아미노피리딘―3―올 유도체 또는 이의 약제학적 허용가능한 염 및 이를 유효성분으로 함유하는 혈관신생으로 인한 질환의 예방 또는 치료용 약학조성물
|
|
GB201204125D0
(en)
|
2012-03-08 |
2012-04-25 |
Karus Therapeutics Ltd |
Compounds
|
|
WO2014032019A2
(en)
|
2012-08-23 |
2014-02-27 |
Georgetown University |
Compounds and methods of use thereof for treating tumors
|
|
EP2917202B1
(en)
|
2012-11-07 |
2018-05-02 |
Karus Therapeutics Limited |
Novel histone deacetylase inhibitors and their use in therapy
|
|
JP6434416B2
(ja)
|
2012-11-08 |
2018-12-05 |
ライゼン・ファーマシューティカルズ・エスアー |
ＰＤＥ４阻害剤とＰＩ３δ阻害剤または二重ＰＩ３δ−γキナーゼ阻害剤とを含有する薬学的組成物
|
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
|
US9970898B2
(en)
*
|
2013-03-13 |
2018-05-15 |
The University Of North Carolina At Chapel Hill |
Nanofluidic devices for the rapid mapping of whole genomes and related systems and methods of analysis
|
|
WO2014139145A1
(en)
|
2013-03-15 |
2014-09-18 |
Hutchison Medipharma Limited |
Novel pyrimidine and pyridine compounds and usage thereof
|
|
WO2014153280A1
(en)
|
2013-03-22 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
CN105358550B
(zh)
|
2013-05-10 |
2018-04-06 |
卡鲁斯治疗有限公司 |
组蛋白脱乙酰基酶抑制剂
|
|
JP6584391B2
(ja)
|
2013-10-10 |
2019-10-02 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
非ホジキンリンパ腫を治療するための、ｈｄａｃ阻害剤単独またはｐｉ３ｋ阻害剤との組み合わせ
|
|
GB201402431D0
(en)
|
2014-02-12 |
2014-03-26 |
Karus Therapeutics Ltd |
Compounds
|
|
US10081624B2
(en)
|
2014-08-26 |
2018-09-25 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
GB201419264D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419228D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201514756D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compound and method of use
|
|
GB201609786D0
(en)
|
2016-06-03 |
2016-07-20 |
Karus Therapeutics Ltd |
Compounds and method of use
|
|
US11066396B2
(en)
|
2016-06-23 |
2021-07-20 |
Merck Sharp & Dohme Corp. |
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
|
|
WO2017222952A1
(en)
|
2016-06-23 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
WO2017222950A1
(en)
|
2016-06-23 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
3-heterocyclyl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
GB201803361D0
(en)
|
2018-03-01 |
2018-04-18 |
Karus Therapeutics Ltd |
Histone deacetylase inhibitors
|